William F Doyle - Net Worth and Insider Trading
William F Doyle Net Worth
The estimated net worth of William F Doyle is at least $11 Million dollars as of 2024-07-27. William F Doyle is the Executive Chairman of NovoCure Ltd and owns about 551,176 shares of NovoCure Ltd (NVCR) stock worth over $10 Million. William F Doyle is the Director of Elanco Animal Health Inc and owns about 76,330 shares of Elanco Animal Health Inc (ELAN) stock worth over $984,657. William F Doyle is also the Director of Minerva Neurosciences Inc and owns about 3,264 shares of Minerva Neurosciences Inc (NERV) stock worth over $9,988. Details can be seen in William F Doyle's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that William F Doyle has not made any transactions after 2024-05-21 and currently still holds the listed stock(s).
Transaction Summary of William F Doyle
William F Doyle Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, William F Doyle owns 7 companies in total, including NovoCure Ltd (NVCR) , Minerva Neurosciences Inc (NERV) , and OptiNose Inc (OPTN) among others .
Click here to see the complete history of William F Doyle’s form 4 insider trades.
Insider Ownership Summary of William F Doyle
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
NVCR | NovoCure Ltd | 2022-08-02 | director & 10 percent owner |
NERV | Minerva Neurosciences Inc | 2019-06-27 | director |
OPTN | OptiNose Inc | 2017-10-12 | director & 10 percent owner |
![]() | ![]() | 2015-02-03 | director |
![]() | ![]() | 2024-05-21 | director |
![]() | ![]() | 2022-07-11 | director |
![]() | ![]() | 2022-07-11 | director |
William F Doyle Latest Holdings Summary
William F Doyle currently owns a total of 3 stocks. Among these stocks, William F Doyle owns 551,176 shares of NovoCure Ltd (NVCR) as of August 2, 2022, with a value of $10 Million and a weighting of 91.34%. William F Doyle owns 76,330 shares of Elanco Animal Health Inc (ELAN) as of May 21, 2024, with a value of $984,657 and a weighting of 8.57%. William F Doyle also owns 3,264 shares of Minerva Neurosciences Inc (NERV) as of June 27, 2019, with a value of $9,988 and a weighting of 0.09%.
Latest Holdings of William F Doyle
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
NVCR | NovoCure Ltd | 2022-08-02 | 551,176 | 19.03 | 10,488,879 |
ELAN | Elanco Animal Health Inc | 2024-05-21 | 76,330 | 12.90 | 984,657 |
NERV | Minerva Neurosciences Inc | 2019-06-27 | 3,264 | 3.06 | 9,988 |
Holding Weightings of William F Doyle
William F Doyle Form 4 Trading Tracker
According to the SEC Form 4 filings, William F Doyle has made a total of 15 transactions in NovoCure Ltd (NVCR) over the past 5 years, including 0 buys and 15 sells. The most-recent trade in NovoCure Ltd is the sale of 837 shares on August 2, 2022, which brought William F Doyle around $58,305.
According to the SEC Form 4 filings, William F Doyle has made a total of 2 transactions in Elanco Animal Health Inc (ELAN) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Elanco Animal Health Inc is the acquisition of 15,000 shares on May 21, 2024, which cost William F Doyle around $254,700.
According to the SEC Form 4 filings, William F Doyle has made a total of 0 transactions in Minerva Neurosciences Inc (NERV) over the past 5 years. The most-recent trade in Minerva Neurosciences Inc is the acquisition of 438 shares on June 27, 2019, which cost William F Doyle around $19,250.
Insider Trading History of William F Doyle
- 1
William F Doyle Trading Performance
GuruFocus tracks the stock performance after each of William F Doyle's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by William F Doyle is -1.34%. GuruFocus also compares William F Doyle's trading performance to market benchmark return within the same time period. The performance of stocks bought by William F Doyle within 3 months outperforms 3 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how William F Doyle's insider trading performs compared to the benchmark.
Performance of William F Doyle
William F Doyle Ownership Network
William F Doyle Owned Company Details
What does NovoCure Ltd do?
Who are the key executives at NovoCure Ltd?
William F Doyle is the director & 10 percent owner of NovoCure Ltd. Other key executives at NovoCure Ltd include Chief Financial Officer Wilhelmus Cm Groenhuysen , President & CNS Cancers US Frank X Leonard , and Chief Commercial Officer Pritesh Shah .
NovoCure Ltd (NVCR) Insider Trades Summary
Over the past 18 months, William F Doyle made no insider transaction in NovoCure Ltd (NVCR). Other recent insider transactions involving NovoCure Ltd (NVCR) include a net sale of 32,769 shares made by Wilhelmus Cm Groenhuysen , a net sale of 24,936 shares made by Pritesh Shah , and a net sale of 22,793 shares made by Frank X Leonard .
In summary, during the past 3 months, insiders sold 2,892 shares of NovoCure Ltd (NVCR) in total and bought 0 shares, with a net sale of 2,892 shares. During the past 18 months, 95,049 shares of NovoCure Ltd (NVCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 95,049 shares.
NovoCure Ltd (NVCR)'s detailed insider trading history can be found in Insider Trading Tracker table.
NovoCure Ltd Insider Transactions
William F Doyle Mailing Address
Above is the net worth, insider trading, and ownership report for William F Doyle. Currently GuruFocus does not have mailing address information for William F Doyle.